Accuvest Global Advisors Johnson & Johnson Transaction History

Accuvest Global Advisors

$151 Million
Q2 2025

A detailed history of Accuvest Global Advisors transactions in Johnson & Johnson stock. As of the latest transaction made, Accuvest Global Advisors holds 1,499 shares of JNJ stock, worth $255,714. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,499

Previous 6,203 75.83%

Holding current value

$255,714

Previous $1.03 Million 77.82%

% of portfolio

0.15%

Previous 0.88%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 05, 2025	SELL	$146.36 - $159.82 $688,477 - $751,793	-4,704 Reduced 75.83%	1,499 $228,000
Q1 2025 May 09, 2025	BUY	$142.06 - $167.7 $881,198 - $1.04 Million	6,203 New	6,203 $1.03 Million
Q3 2024 Nov 12, 2024	BUY	$145.48 - $167.38 $432,657 - $497,788	2,974 New	2,974 $481,000
Q1 2024 May 14, 2024	SELL	$155.22 - $162.74 $98,875 - $103,665	-637 Reduced 17.49%	3,006 $475,000
Q4 2023 Feb 13, 2024	SELL	$145.6 - $158.88 $144,435 - $157,608	-992 Reduced 21.4%	3,643 $571,000
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $190,793 - $213,738	-1,225 Reduced 20.9%	4,635 $721,000
Q2 2023 Aug 11, 2023	SELL	$154.35 - $166.11 $3,704 - $3,986	-24 Reduced 0.41%	5,860 $969,000
Q1 2023 May 12, 2023	SELL	$151.05 - $180.26 $701,476 - $837,127	-4,644 Reduced 44.11%	5,884 $912,000
Q4 2022 Jan 12, 2023	BUY	$160.2 - $179.79 $837,365 - $939,762	5,227 Added 98.6%	10,528 $0
Q3 2022 Oct 20, 2022	BUY	$161.33 - $179.52 $67,435 - $75,039	418 Added 8.56%	5,301 $866,000
Q2 2022 Aug 12, 2022	SELL	$168.19 - $186.01 $564,782 - $624,621	-3,358 Reduced 40.75%	4,883 $867,000
Q1 2022 May 06, 2022	BUY	$158.14 - $179.59 $184,707 - $209,761	1,168 Added 16.51%	8,241 $1.46 Million
Q4 2021 Jan 28, 2022	BUY	$155.93 - $173.01 $228,437 - $253,459	1,465 Added 26.12%	7,073 $1.21 Million
Q3 2021 Nov 03, 2021	SELL	$161.5 - $179.47 $98,192 - $109,117	-608 Reduced 9.78%	5,608 $920,000
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $991,327 - $1.06 Million	6,216 New	6,216 $1.02 Million
Q1 2021 Aug 16, 2021	SELL	$153.07 - $170.48 $339,203 - $377,783	-2,216 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$140.38 - $153.83 $439,950 - $482,103	-3,134 Reduced 58.58%	2,216 $330,000
Q2 2020 Jul 15, 2020	SELL	$128.81 - $155.51 $38,385 - $46,341	-298 Reduced 5.28%	5,350 $752,000
Q1 2020 Apr 23, 2020	BUY	$111.14 - $153.99 $627,718 - $869,735	5,648 New	5,648 $741,000
Q1 2019 Apr 30, 2019	SELL	$125.72 - $139.79 $1.28 Million - $1.43 Million	-10,194 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $307,468 - $370,043	2,503 Added 32.54%	10,194 $1.32 Million
Q3 2018 Oct 31, 2018	BUY	$121.58 - $142.88 $935,071 - $1.1 Million	7,691 New	7,691 $1.06 Million

Others Institutions Holding JNJ

# of Institutions

4,629

Shares Held

1.72B

Call Options Held

25M

Put Options Held

15.6M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $446B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Accuvest Global Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Accuvest Global Advisors with notifications on news.

Account

Accuvest Global Advisors Johnson & Johnson Transaction History